Phase 2 Multiple Sclerosis Trial, Recruiting ISRCTN57749443 Sponsor: University of Liverpool Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Phase 2 Multiple Sclerosis Trial, Recruiting

ISRCTN57749443
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People with multiple sclerosis (MS):

  • Adults diagnosed with primary progressive, secondary progressive, or relapsing-remitting MS.
  • People whose MS-related disability falls within a specific range — roughly meaning they can walk up to 500 metres without an aid at the lower end, or need two walking aids to walk about 20 metres at the upper end (confirm with trial site for exact scoring).

Carers or support people:

  • People who provide informal or formal care to someone with MS involved in the study, including helping with hospital visits, using the muscle stimulation device, or recording health and activity information.

Healthcare staff:

  • Clinical and non-clinical staff who were involved in setting up or running the study.

Who may not be able to join:

People with multiple sclerosis (MS):

  • People diagnosed with clinically isolated syndrome (an early MS-like episode, not yet confirmed as MS).
  • People currently experiencing an MS relapse, or who have had a relapse within the past 8 weeks.
  • People with a nerve injury in the lower limbs.
  • People with fixed stiffness or tightening of muscles in the lower limbs that cannot be moved (fixed contractures).
  • People for whom electrical muscle stimulation on the skin would not be safe, including those who are pregnant, have uncontrolled epilepsy, have a lower-limb nerve injury, have an unstable bone or joint condition in the lower limbs, have cancer in the area where the device pads would be placed, or have a skin infection or damaged skin at that site.
  • People who are unable to operate the electrical stimulation device and leg braces on their own or with carer help.
  • People with other conditions that significantly affect mobility, such as a history of stroke (note: a heart pacemaker or cardiac history alone is not automatically disqualifying, but a cardiologist's approval would be required — confirm with trial site).

Carers or support people:

  • Carers or support people who were not directly involved in the study are not eligible to participate as carers in this trial.

Healthcare staff:

  • Healthcare practitioners or staff who were not involved in setting up or delivering the study are not eligible to participate in this capacity.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from the ISRCTN registry. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 10 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
University of Liverpool
Registry
ISRCTN registry
Start date
3 October 2025
Est. completion
1 October 2027

Where this trial is recruiting

England 🇬🇧 United Kingdom

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from the ISRCTN registry: 10 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ISRCTN ↗

Source: ISRCTN registry (isrctn.com), data processed 10 July 2026. ISRCTN metadata is CC0; contribution content is CC BY 4.0.